2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Ovarian Neoplasms
104
Breast Neoplasms
76
Fallopian Tube Neoplasms
47
Multiple Myeloma
32
Carcinoma, Ovarian Epithelial
27
Neoplasms
23
Lymphoma
16
Sarcoma
13
Triple Negative Breast Neoplasms
12
Recurrence
12
Neoplasm Metastasis
12
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Non-Hodgkin
8
Hodgkin Disease
8
Neoplasms, Plasma Cell
6
Prostatic Neoplasms
5
Burkitt Lymphoma
5
Solid Tumors
4
Sarcoma, Kaposi
4
Sarcoma, Ewing
4
Pancreatic Neoplasms
4
Lymphoma, T-Cell, Peripheral
4
Lymphoma, Mantle-Cell
4
Leiomyosarcoma
4
Endometrial Neoplasms
4
Carcinoma
4
Breast Neoplasms, Male
4
Uterine Cervical Neoplasms
3
Rhabdomyosarcoma
3
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Interventions
Radiotherapy
10
Cisplatin
9
pembrolizumab
6
Surveys and Questionnaires
6
Methods
6
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
5
fludarabine
4
Papillomavirus Vaccines
4
Early Intervention, Educational
4
Cyclophosphamide
4
Brachytherapy
4
durvalumab
3
aldesleukin
3
Vaccines, Synthetic
3
Vaccines
3
Sentinel Lymph Node Biopsy
3
Radiosurgery
3
Radiation
3
Platinum
3
Palliative Care
3
Paclitaxel
3
Nivolumab
3
Indocyanine Green
3
Gemcitabine
3
Drug Therapy
3
Carboplatin
3
Bleomycin
3
Biopsy
3
1,2-diaminocyclohexaneplatinum II citrate
3
tremelimumab
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Vulvar Neoplasms
×
liposomal doxorubicin
×
Clear all
NCT06023862
2026-05-06
DOVE
Yonsei University
Phase 2
Recruiting
198 enrolled